Munich - Delayed Quote EUR
Mersana Therapeutics Inc (0M4.MU)
0.2908
-0.0398
(-12.04%)
As of 8:00:12 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-82,340
-82,340
-168,882
-49,363
-139,988
Investing Cash Flow
11,437
11,437
119,883
-152,716
-648
Financing Cash Flow
4,092
4,092
94,675
153,017
63,646
End Cash Position
108,228
108,228
175,039
129,363
178,425
Income Tax Paid Supplemental Data
418
418
--
--
--
Interest Paid Supplemental Data
3,467
3,467
3,380
2,463
429
Capital Expenditure
-132
-132
-2,168
-2,197
-648
Issuance of Capital Stock
5,780
5,780
93,539
150,893
43,087
Issuance of Debt
--
--
--
--
24,042
Repayment of Debt
-2,230
-2,230
-412
-272
-5,701
Free Cash Flow
-82,472
-82,472
-171,050
-51,560
-140,636
12/31/2021 - 3/26/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
38I.SG Intellia Therapeutics Inc
7.11
-0.62%
IGC IGC Pharma, Inc.
0.2922
+0.55%
AZTR Azitra, Inc.
0.2805
+0.86%
ELEV Elevation Oncology, Inc.
0.2998
-12.24%
CYCC Cyclacel Pharmaceuticals, Inc.
2.2000
-5.17%
SPRY ARS Pharmaceuticals, Inc.
12.20
+0.79%
ABSI Absci Corporation
2.9600
+1.72%
HUMA Humacyte, Inc.
1.8900
+1.07%
RXRX Recursion Pharmaceuticals, Inc.
4.2500
-1.39%
CRSP CRISPR Therapeutics AG
36.31
+1.99%